Liver dysfunction of Atezolizumab + Bevacizumab -a matter of life or death−

Shuntaro Obi; Masao Omata

doi:10.1111/liv.14947

Liver dysfunction of Atezolizumab + Bevacizumab -a matter of life or death−

Shuntaro Obi
, Masao Omata

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	1702-1703
Number of pages	2
Journal	Liver International
Volume	41
Issue number	7
DOIs	https://doi.org/10.1111/liv.14947
State	Published - Jul 2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/liv.14947

Cite this

@article{1fc1e519ccd442f3a5b0304085d64872,

title = "Liver dysfunction of Atezolizumab + Bevacizumab -a matter of life or death−",

author = "Shuntaro Obi and Masao Omata",

year = "2021",

month = jul,

doi = "10.1111/liv.14947",

language = "英語",

volume = "41",

pages = "1702--1703",

journal = "Liver International",

issn = "1478-3223",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "7",

}

TY - JOUR

T1 - Liver dysfunction of Atezolizumab + Bevacizumab -a matter of life or death−

AU - Obi, Shuntaro

AU - Omata, Masao

PY - 2021/7

Y1 - 2021/7

UR - https://www.scopus.com/pages/publications/85106577879

U2 - 10.1111/liv.14947

DO - 10.1111/liv.14947

M3 - 手紙

C2 - 34049421

AN - SCOPUS:85106577879

SN - 1478-3223

VL - 41

SP - 1702

EP - 1703

JO - Liver International

JF - Liver International

IS - 7

ER -

Liver dysfunction of Atezolizumab + Bevacizumab -a matter of life or death−

UN SDGs

Access to Document

Other files and links

Cite this